Next Article in Journal
Correlations of Host and Bacterial Characteristics with Clinical Parameters and Survival in Staphylococcus aureus Bacteremia
Next Article in Special Issue
Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience
Previous Article in Journal
Pregnancy and Neonatal Outcomes after Transfer of Mosaic Embryos: A Review
Article

Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)

1
Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
2
Clinical Laboratory, University of Tsukuba Hospital, Tsukuba 305-8576, Japan
3
Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
4
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
5
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
6
Department of Cardiology, Mito Kyodo General Hospital, Mito 310-0015, Japan
7
Department of Medical Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Doris Howell
J. Clin. Med. 2021, 10(7), 1370; https://doi.org/10.3390/jcm10071370
Received: 28 February 2021 / Revised: 19 March 2021 / Accepted: 25 March 2021 / Published: 27 March 2021
As the number of cancer survivors increases, cardiac management in anthracycline-treated patients has become more important. We planned to conduct a prospective multicenter registry study for comprehensive echocardiographic and biomarker data collection and an evaluation of the current practice in terms of diagnosis and management of anthracycline-induced cardiotoxicity (AIC registry). To examine the feasibility of this registry study, we analyzed the 1-year follow-up data of 97 patients registered during the first year of this registry. The AIC registry was launched in July 2016. Data on echocardiographic parameters (e.g., two-and three-dimensional [(2- and 3-D) left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS)) and biomarkers (e.g., troponin T and brain natriuretic peptide) were collected before anthracycline treatment, every 3 months during the first year after starting anthracycline, and every 6 months during the second year. Eighty-three patients (86%) completed a 1-year follow-up. The measurable rates of 2D LVEF, 3D LVEF, and GLS on each visit were nearly optimal (100%, 86–93%, and 84–94%, respectively). During the 1-year follow-up, 5 patients (6.0%) developed cardiotoxicity (a reduction in LVEF ≥ 10 percentage points from baseline and <55%). The AIC registry study is feasible and will be the first study to collect sizable echocardiographic and biomarker data on cardiotoxicity in Japanese patients treated with anthracycline in a real-world setting. View Full-Text
Keywords: anthracycline; cardiotoxicity; cardiomyopathy; onco-cardiology; cardio-oncology; echocardiography; biomarker anthracycline; cardiotoxicity; cardiomyopathy; onco-cardiology; cardio-oncology; echocardiography; biomarker
Show Figures

Figure 1

MDPI and ACS Style

Inoue, K.; Iida, N.; Tajiri, K.; Bando, H.; Chiba, S.; Tasaka, N.; Nagashio, K.; Sasamura, R.; Naito, H.; Murata, M.; Li, S.; Ishizu, T.; Nakazawa, Y.; Sekine, I.; Ieda, M. Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry). J. Clin. Med. 2021, 10, 1370. https://doi.org/10.3390/jcm10071370

AMA Style

Inoue K, Iida N, Tajiri K, Bando H, Chiba S, Tasaka N, Nagashio K, Sasamura R, Naito H, Murata M, Li S, Ishizu T, Nakazawa Y, Sekine I, Ieda M. Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry). Journal of Clinical Medicine. 2021; 10(7):1370. https://doi.org/10.3390/jcm10071370

Chicago/Turabian Style

Inoue, Keiko, Noriko Iida, Kazuko Tajiri, Hiroko Bando, Shigeru Chiba, Nobutaka Tasaka, Kenji Nagashio, Rumi Sasamura, Hiroyuki Naito, Momoko Murata, Siqi Li, Tomoko Ishizu, Yoko Nakazawa, Ikuo Sekine, and Masaki Ieda. 2021. "Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)" Journal of Clinical Medicine 10, no. 7: 1370. https://doi.org/10.3390/jcm10071370

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop